5:33 PM
Sep 07, 2012
 |  BC Extra  |  Financial News

Regulus sets IPO range

Regulus Therapeutics Inc. (San Diego, Calif.) amended its IPO and now plans to sell 4.5 million shares at $10-$12 per share. An $11 price would raise $50 million and value the company...

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >